Sunday, March 29, 2009

COURT REPORT

About Court Report: Every week http://www.patentdocs.org/ report briefly on recently filed biotech and pharma cases, and they select few interesting cases for periodic monitoring.

Cubist Pharmaceuticals Inc. v. Teva Parenteral Medicines Inc. et al.1:09-cv-00189; filed March 23. 2009 in the District Court of Delaware (daptomycin for injection)

Sepracor Inc. v. Teva Pharmaceuticals USA, Inc. et al.2:09-cv-01302; filed March 20, 2009 in the District Court of New Jersey (eszopiclone, used to treat insomnia)

OSI Pharmaceuticals Inc. et al. v. Mylan Pharmaceuticals Inc.1:09-cv-00186; filed March 19, 2009 in the District Court of Delaware

&

OSI Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA Inc. 1:09-cv-00185; filed March 19, 2009 in the District Court of Delaware (erlotinib)

Research Foundation of State University of New York et al. v. Mylan Pharmaceuticals Inc.1:09-cv-00184; filed March 19, 2009 in the District Court of Delaware (doxycyline delayed release capsules)

Shire Canada Inc. et al. v. Mylan Inc. et al. 1:09-cv-02555; filed March 19, 2009 in the Southern District of New York (Lanthanum Carbonate)

The detailed complaints can be read here.

No comments: